A detailed history of Geode Capital Management, LLC transactions in Scynexis Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 398,856 shares of SCYX stock, worth $502,558. This represents 0.0% of its overall portfolio holdings.

Number of Shares
398,856
Previous 362,451 10.04%
Holding current value
$502,558
Previous $724,000 17.96%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.27 - $2.23 $46,234 - $81,183
36,405 Added 10.04%
398,856 $594,000
Q2 2024

Aug 09, 2024

BUY
$1.4 - $2.77 $10,137 - $20,057
7,241 Added 2.04%
362,451 $724,000
Q1 2024

May 13, 2024

SELL
$1.39 - $2.21 $977 - $1,553
-703 Reduced 0.2%
355,210 $522,000
Q4 2023

Feb 13, 2024

BUY
$1.56 - $2.24 $26,474 - $38,015
16,971 Added 5.01%
355,913 $793,000
Q3 2023

Nov 13, 2023

BUY
$1.93 - $3.64 $51,700 - $97,508
26,788 Added 8.58%
338,942 $772,000
Q2 2023

Aug 11, 2023

BUY
$2.38 - $3.67 $109,779 - $169,282
46,126 Added 17.34%
312,154 $920,000
Q4 2022

Feb 13, 2023

SELL
$1.46 - $2.94 $24,476 - $49,289
-16,765 Reduced 5.93%
266,028 $415,000
Q3 2022

Nov 14, 2022

BUY
$1.83 - $2.93 $91,624 - $146,699
50,068 Added 21.51%
282,793 $678,000
Q2 2022

Aug 12, 2022

BUY
$1.77 - $3.87 $37,231 - $81,405
21,035 Added 9.94%
232,725 $432,000
Q1 2022

May 13, 2022

BUY
$3.56 - $6.66 $137,939 - $258,055
38,747 Added 22.4%
211,690 $827,000
Q4 2021

Feb 11, 2022

BUY
$4.94 - $7.69 $66,793 - $103,976
13,521 Added 8.48%
172,943 $1.05 Million
Q3 2021

Nov 12, 2021

SELL
$5.3 - $7.89 $25,090 - $37,351
-4,734 Reduced 2.88%
159,422 $844,000
Q2 2021

Aug 13, 2021

BUY
$6.5 - $9.97 $186,251 - $285,680
28,654 Added 21.15%
164,156 $1.21 Million
Q1 2021

May 12, 2021

BUY
$6.93 - $9.63 $428,086 - $594,873
61,773 Added 83.78%
135,502 $1.08 Million
Q4 2020

Feb 12, 2021

BUY
$4.28 - $7.87 $25,919 - $47,660
6,056 Added 8.95%
73,729 $564,000
Q3 2020

Nov 13, 2020

BUY
$4.37 - $7.48 $295,731 - $506,194
67,673 New
67,673 $298,000

Others Institutions Holding SCYX

About SCYNEXIS INC


  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $41.1M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.